Gamunex-c 20 gram/200 ML vial 200ML
Ended Awarded Last action
- Contract number
- SPE2DR26FU147
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,310
Award facts
- Contract value 100% obligated
- $37,310.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $37,310.40 by the Defense Logistics Agency on November 24, 2025, for the supply of Gamunex-C (immune globulin intravenous [human] 20g/200mL vials). The award is a firm fixed-price, non-competitive delivery order with an ultimate completion date of December 16, 2025, and will be performed at the contractor's Conshohocken facility. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs.
The Defense Logistics Agency awards such delivery orders to sustain the pharmaceutical supply chain supporting military medical operations and veteran healthcare systems. AmerisourceBergen's extensive federal contract portfolio demonstrates proven capability in delivering specialized medical products, including immunological treatments like Gamunex-C, which is utilized for immunodeficiency conditions and other clinical indications requiring intravenous immunoglobulin therapy. The firm fixed-price structure and accelerated delivery timeline reflect the critical nature of pharmaceutical procurement within the federal medical supply chain, ensuring timely availability of essential healthcare commodities to support military readiness and personnel health.
Quick answers
Who was awarded contract SPE2DR26FU147?
SPE2DR26FU147 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FU147 worth?
The government has obligated $37,310 on SPE2DR26FU147.
Is contract SPE2DR26FU147 an order under another contract?
Yes. SPE2DR26FU147 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU147 competed?
The extent of competition for SPE2DR26FU147 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award